Hemabate
Brand for: Carboprost
My Prescription
Payment
Select pharmacy
$20.96
Print or send this coupon to your phone
AlbertsonsPowered byAbout Hemabate
Drug Details
Carboprost, marketed as Hemabate, is an injectable medication administered by healthcare professionals in a hospital setting. It is primarily used for two purposes: to medically terminate a pregnancy between the 13th and 20th week and to manage postpartum bleeding when other treatments have failed. This drug works by inducing uterine contractions, which help in achieving its intended effects. Always consult with a healthcare provider for advice tailored to your medical needs before using this medication.
Hemabate (Carboprost) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 250MCG/ML | 1 Vial | $20.96 | $20.96 |
| 1ML of 250MCG/ML | 2 Vials | $33.92 | $16.96 |
| 1ML of 250MCG/ML | 3 Vials | $46.88 | $15.63 |
Hemabate FAQs
Hemabate is a medication that contains carboprost tromethamine, a synthetic prostaglandin analogue. It is primarily used to treat postpartum hemorrhage due to uterine atony and to induce abortion in the second trimester of pregnancy.
HEMABATE should not be given to individuals with a known hypersensitivity to carboprost or any of its components. It is also contraindicated in patients with acute pelvic inflammatory disease, active cardiac, pulmonary, renal, or hepatic disease. Additionally, it should not be used in patients with a history of asthma due to the risk of bronchospasm.
Hemabate (carboprost tromethamine) is not typically used to induce labor. It is primarily used to treat severe postpartum hemorrhage due to uterine atony, which is when the uterus fails to contract after childbirth. It helps control bleeding by stimulating uterine contractions.
The real name for HEMABATE is carboprost tromethamine.
Carboprost is not administered in cases where the patient has a known hypersensitivity to the drug or any of its components. It is also contraindicated in patients with active cardiac, pulmonary, renal, or hepatic disease. Additionally, it should not be used in patients with a history of asthma due to the risk of bronchospasm.